Like Viewics, Inc.

announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/18/2021 via BusinessWire

Verily Life Sciences, will acquire SignalPath

synopsis: Verily, an Alphabet company focused on life sciences and healthcare, will acquire SignalPath, a clinical trial management system (CTMS) that improves the ease and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
buyer parent: Google
buyer: Verily Life Sciences
Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. The company develops tools to collect and activate health data, and creates interventions to prevent and manage disease. "
target: SignalPath
SignalPath is a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2021 via BusinessWire

Francisco Partners Management LLC, will acquire STARLIMS

synopsis: Francisco Partners is to acquire the STARLIMS informatics product suite and related business assets from Abbott. A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Francisco Partners has raised approximately $25 billion in committed capital and invested in more than 300 technology companies. "
target parent: Abbott Laboratories
target: STARLIMS (LIMS:$25.24)
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/6/2019 via BNC Analysis

Advarra, will acquire Forte Research Systems

synopsis: Advarra, the premier provider of institutional review board, institutional biosafety committee, and research quality and compliance consulting services, will acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Primus
target: Forte Research Systems
Forte provides software and services in the critical areas of clinical trial management, clinical data management, and research administration for cancer centers, academic medical centers, and health systems. Forte's flagship Clinical Trial Management System, OnCore manages clinical research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 1/27/2015 via PR Newswire

genae, acquired e-novex

synopsis: genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced the acquisition of e-novex, a leading provider of electronic data tools that change medical research. e-novex' proprietory Electronic Data Capture (EDC) technology is widely adopted by various types of medical research organizations.
buyer: genae
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. As a full service CRO and innovative services provider for the medical industries, genae aims at improving health and quality of life. "
target: e-novex
e-novex is a certified web technology company that provides electronic data tools that facilitates medical research. e-capture.net is an intuitive and user-centric EDC platform that features easy data entry, complex validation rules and flexible reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

ERT, acquired invivodata, Inc.

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes (ePRO) solutions and Consulting services, based in Pittsburgh, PA.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. "
target: invivodata, Inc.
invivodata is a fully-integrated Clinical Outcome Assessments organization delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2020 via BusinessWire

GI Partners, acquired Clinical Ink

synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer: GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent: NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/15/2018 via Company Press Release

NovaQuest, acquired Clinical Ink

synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer: NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2022 via PR Newswire

TriNetX, acquired Advera Health Analytics Inc.

synopsis: TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, announced the acquisition of Advera Health Analytics, the leader in pharmacovigilance software and data for detection, management, and mitigation of drug safety concerns.
buyer: TriNetX
TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. TriNetX combines real-time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions. "
target: Advera Health Analytics Inc.
Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Advera Health's Evidex platform connects disparate drug safety data sources and provides a user experience that elicits actionable intelligence from that data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/11/2018 via Company Press Release

Genpact Ltd, will acquire Commonwealth Informatics Inc.

synopsis: Genpact, a professional services firm focused on delivering digital transformation, announced that it has signed a definitive agreement to acquire Commonwealth Informatics, Inc. (CI), a market-leading provider of cloud-based drug safety analytics products and services for medical research and healthcare delivery headquartered near Boston, Mass.
buyer: Genpact Ltd (G:$3,699.55)
Genpact is a global professional services firm that makes business transformation real. They drive digital-led innovation and digitally-enabled intelligent operations for their clients. They think with design, dream in digital, and solve problems with data and analytics. "
target: Commonwealth Informatics Inc.
Commonwealth Informatics provides cloud-based drug safety analytics products and services for medical research and healthcare delivery. Their Commonwealth Vigilance Workbench consists of integrated modules used by pharmaceutical and biotech companies, government agencies, and healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/14/2020 via PR Web

Amsys Group, acquired HealthConnexx LLC

synopsis: AMSYS Group, an international group of companies, has acquired HealthConnexx, a healthcare technology company. HealthConnexx, through its RxConnexx platform, connects providers, patients, payers, pharmacies, and pharmaceutical companies to prescription medication information to enable better clinical outcomes through real-time data.
buyer: Amsys Group
AMSYS Group is a 17-year old firm with experience in multiple verticals. IT is their flagship vertical. The group offers a variety of managed IT services and IT staffing solutions. Their other verticals include emerging tech, telecom engineering, oil and gas services, compliance, and healthcare. "
target: HealthConnexx LLC
HealthConnexx is an innovator for healthcare data liquidity and accessibility. The HealthConnexx RxConnexx platform is the first real-time patient data exchange platform for medication and benefits data, bringing immediate clarity and actionable information for everyone in the healthcare continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2012 via BusinessWire

Pharmaceutical Strategies Group, LLC, acquired Artemetrx

synopsis: Pharmaceutical Strategies Group, LLC, America’s largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources. Artemetrx offers data analytic tools and clinical programs that integrate pharmacy, medical, and other healthcare information.
buyer: Pharmaceutical Strategies Group, LLC
Pharmaceutical Strategies Group, LLC assists plan sponsors and other payors, Taft-Hartley Unions, large employers, and health systems in designing, implementing, and managing programs that maximize the value and impact of pharmaceuticals in their population. "
target: Artemetrx
At the core of the Artemetrx service offering is a robust proprietary data aggregation engine that combines behavioral, medical, dental, vision, lab, and prescription drug data to provide a comprehensive view of health-related utilization and expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via PR Newswire

Velocity Clinical Research, acquired TrierHealth

synopsis: Velocity Clinical Research, the leading integrated site organization for clinical trials, has acquired TrierHealth, an India-based platform that enables digital clinical trials. TrierHealth is a mobile platform that allows users to improve patient engagement through analytics and instantly digitize clinical data by applying deep AI algorithms.
buyer: Velocity Clinical Research
Velocity Clinical Research is the leading integrated site organization for clinical trials. Velocity offers dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. "
target: TrierHealth
TrierHealth is an India-based platform that enables digital clinical trials. TrierHealth is a secure, mobile platform that allows users to improve patient engagement through analytics and instantly digitize clinical data by applying deep AI algorithms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/19/2021 via BNC Analysis

Glintt, acquired FarmaTools

synopsis: Glintt, a leading consulting and technological services company based in Portugal, has acquired FarmaTools from Dominion Global, a global provider of multitechnology services. FarmaTools is a hospital pharmacy software solutions provider in Spain. Their software provides solutions for administrative management and clinical management.
buyer: Glintt (ENXTLS:GLINT:$108.88)
Glintt is a leading consulting and technological services company based in Portugal. Glintt develops products for hospitals, clinics and pharmacies. They support their clients in their digital transformation and offers software solutions that helps them to run their business more efficiently. "
target parent: Dominion Global
target: FarmaTools
FarmaTools is a pharmacy software solutions provider in Spain. FarmaTools offers an innovative, effective, and automated system for hospital pharmacies. Their software provides solutions for administrative management and clinical management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2020 via Company Press Release

Inmar Inc., acquired RXTransparent

synopsis: Inmar has announced that it has acquired Forerunner Holdings Inc., the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
buyer parent: OMERS Private Equity
buyer: Inmar Inc.
Inmar’s holistic portfolio of media products enables advertisers to access a variety of intelligent tools, including its influencer media platform, conversational commerce (chat-based media), audience extension and on-site digital media for retail. "
target: RXTransparent
Forerunner Holdings Inc. are the developers of RXTransparent, an SAAS platform allowing healthcare providers to put their finger on the pulse of drug supply chain through product inventory transparency, regulatory compliance and supply chain analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2019 via GlobeNewswire

Tabula Rasa Healthcare, acquired DoseMe

synopsis: Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, has acquired DoseMe. DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications. DoseMe is based in the US and Australia.
buyer: Tabula Rasa Healthcare (TRHC:$204.27)
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. "
target: DoseMe
DoseMe is the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/15/2018 via Company Press Release

Roche Ltd, will acquire Flatiron Health

synopsis: Flatiron Health, Inc. announced that it has signed a definitive agreement under which Roche will acquire all shares of Flatiron Health. Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Flatiron Health
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. The Flatiron platform enables cancer researchers and care providers to learn from the experience of every patient.
price ($mm)
$1,900*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/30/2017 via Company Press Release

Roche Ltd, acquired mySugr GmbH

synopsis: Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: mySugr GmbH
mySugr specializes in all-around care for people with diabetes. Its apps and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2014 via PR Newswire

Roche Ltd, acquired Bina Technologies

synopsis: Bina Technologies, Inc. announced that they have been acquired by Roche. Bina Technologies is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets. Bina will be integrated into the Roche Sequencing Unit.
buyer: Roche Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. "
target: Bina Technologies
Bina Technologies builds technologies for scalable and accurate processing and management of genomic information. Bina's Genomic Management Solution is an integrated and scalable analysis platform that empowers clinical and translational researchers to gain insight from their genomic data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/13/2010 via PR Newswire

Roche Ltd, will acquire Medical Automation Systems, Inc.

synopsis: Roche and Medical Automation Systems, Inc. (MAS) announced that they have signed an agreement under which Roche will acquire certain assets from MAS. Under the terms of the agreement, Roche will acquire all the assets associated with the RALS point-of-care (POC) information technology (IT) connectivity system.
buyer: Roche Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. "
target: Medical Automation Systems, Inc.
Medical Automation Systems, Inc. (MAS) is a leading provider of POC (point of care) information management systems. In addition to the RALS system, MAS provides informatics solutions for critical care applications including inpatient IV insulin dosing software and ICU outcomes reporting software.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/23/2010 via Company Press Release

Ventana Medical Systems, Inc., acquired BioImagene

synopsis: Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. The purchase price is approximately 100 million US dollars on a debt-free basis.
buyer parent: Roche Ltd
buyer: Ventana Medical Systems, Inc.
Ventana develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. "
target: BioImagene
BioImagene provides sophisticated bio-image analysis products built on iHarness, its patent-pending technology platform. BioImagene's products allow physicians and researchers to analyze and interpret images with far greater speed and consistency.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Viewics, Inc.


read more

Viewics, Inc.

SignalPath

STARLIMS

Habitu Health

Forte Research Systems

OmniComm Systems, Inc.

e-novex

invivodata, Inc.

HealthMode

Bio-Optronics Group, LLC

Clinical Ink

Clinical Ink

Advera Health Analytics Inc.

Commonwealth Informatics Inc.

HealthConnexx LLC

Artemetrx

TrierHealth

FarmaTools

RXTransparent

DoseMe

read more

Viewics, Inc.

read more

Flatiron Health

Viewics, Inc.

mySugr GmbH

Bina Technologies

Medical Automation Systems, Inc.

BioImagene

read more
Geography
Matching Companies
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2021
rev ($mm)
$914.37
EBITDA ($mm)
$99.36
EBIT ($mm)
$57.86
Net Income ($mm)
$35.01
Employees
2970
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: OTCPK:LFER
 
 
 
 
 
 
 
 
Life on Earth, Inc.
Life on Earth, Inc.
Life on Earth is a cloud enterprise software developer. Life on Earth's mission is to rapidly grow their cloud based software and technology solutions to enable secure, smart, compliant and maintainable enterprise business solutions. The company focuses on fast emerging technologies.
year
2021
rev ($mm)
$0.03
EBITDA ($mm)
($0.64)
EBIT ($mm)
($0.96)
Net Income ($mm)
Employees
9
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCQB: EHVVF
 
 
 
 
 
 
 
 
Ehave, Inc.
Ehave, Inc.
Ehave is a healthcare company developing a next generation of digital solutions for stakeholders in the medical cannabis and mental health sectors. Ehave’s health informatics platform efficiently captures high-quality, objective user data.
year
2020
rev ($mm)
EBITDA ($mm)
($2.05)
EBIT ($mm)
($2.85)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: LSE:PRTC
 
 
 
 
 
 
 
 
PureTech Health
PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and more.
year
2019
rev ($mm)
$9.81
EBITDA ($mm)
($132.05)
EBIT ($mm)
($135.40)
Net Income ($mm)
$421.14
Employees
300
  • drill down
  • watch
Ticker: OTCPK:MATN
 
 
 
 
 
 
 
 
Mateon Therapeutics, Inc.
Mateon Therapeutics, Inc.
Mateon Therapeutics is a biopharmaceutical company developing vascular disrupting agents (VDAs) which may be used in combination with currently available anti-angiogenic agents to improve the treatment of cancer, specifically orphan oncology indications.
year
2018
rev ($mm)
EBITDA ($mm)
($0.68)
EBIT ($mm)
($0.71)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch